It is administered as a once-weekly subcutaneous injection in clinical trials, a delivery method consistent with other agents in the incretin-based therapy class, such as semaglutide and tirzepatide
Aim for 30g of fibre daily, increasing intake gradually to minimise bloating
Supplementary information Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Yang F, Kemp CJ, Henikoff S
[99] In contrast to generics, which may be chemically synthesized versions manufactured using different processes than the original biologic drug, Health Canada confirmed that Plosbrio and Poviztra differ from the existing proprietary drugs Ozempic and Wegovy only in name and packaging, and are unrelated to the generics from a regulatory perspective